Arcutis Biotherapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Arcutis Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Arcutis Biotherapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Arcutis Biotherapeutics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $4.6M | 327k | 13.93 |
| 2024-09-30 | $833k | 90k | 9.30 |
| 2024-06-30 | $508k | 55k | 9.30 |
| 2024-03-31 | $7.1M | 716k | 9.91 |
| 2023-12-31 | $41k | 13k | 3.24 |
| 2023-09-30 | $884k | 177k | 5.00 |
| 2023-03-31 | $2.7M | 244k | 11.00 |
| 2022-12-31 | $2.0M | 133k | 14.80 |
| 2022-09-30 | $3.1M | 161k | 19.11 |
| 2021-12-31 | $2.5M | 120k | 20.74 |
| 2021-03-31 | $1.5M | 53k | 28.93 |
| 2020-12-31 | $153k | 5.4k | 28.19 |
| 2020-09-30 | $290k | 9.9k | 29.34 |
| 2020-06-30 | $91k | 3.0k | 30.22 |
| 2020-03-31 | $90k | 3.0k | 29.86 |